Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Market Access
  • Medicare Advantage Out-of-Pocket Limits: Variation and Trends
  • Market Access

Medicare Advantage Out-of-Pocket Limits: Variation and Trends

KFF Medicare

This brief analyzes out-of-pocket limits in Medicare Advantage plans in 2026, variation by plan type, the distribution of enrollees facing different out-of-pocket limits, and trends over time.

Read full story

pharminent May 28, 2026 (Last updated: May 29, 2026)

KFF Medicare

This brief analyzes out-of-pocket limits in Medicare Advantage plans in 2026, variation by plan type, the distribution of enrollees facing different out-of-pocket limits, and trends over time.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
Next: Ahead of ASCO data drop, AZ gets key Imfinzi approval

Related Stories

  • Market Access

NICE aims to cut funding for Amgen lung cancer drug Lumykras

pharminent July 9, 2026
  • Market Access

UK, pharma industry pilot rapid access routes for medicines

pharminent July 5, 2026
  • Market Access

Medicare GLP-1 Bridge Launches July 1 With $50 Copays

pharminent July 3, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.